Results showed that higher mRNA expression of SLC2A4 and SLC2A11 significantly associated with better prognosis of breast cancer patients (HR: 0.7 [0.55–0.88];p =0.0024 and HR: 0.45 [0.33–0.62];p =5E-07, respectively). Here, SLC2A4 is linked to breast carcinoma.